Lino-Silva Leonardo S, Castillo-Medina Ana L, Salcedo-Hernández Rosa A, García-Pérez Leticia
Departments of aAnatomic Pathology bOncologic Surgery, Instituto Nacional de Cancerología, Mexico City cClinical Research, Medicine Faculty, Mexico's State Autonomous University, Estado de México, Mexico.
Melanoma Res. 2017 Apr;27(2):116-120. doi: 10.1097/CMR.0000000000000319.
The objective of this study is to determine whether a less exhaustive pathologic work-up to detect melanoma metastasis is clinically useful and does not affect patient prognosis. The success and evolution of the sentinel lymph node (SLN) depends on histological techniques. Several exhaustive protocols of SLN analysis have been published, but are time and cost consuming, with slight increases in the rates of metastasis detection. From 281 patients with SLN biopsy, each SLN was sectioned every 2 mm and from each paraffin block, 2-3 histological sections were evaluated. The patients were divided as follows: the first group (n=185) was subjected to extensive SLN examination (eSLNe) and the second group (n=96) was not subjected to an extensive SLN examination (wSLNe). The average SLN resected was 2 (range: 1-7), evaluating one in 50.9%. The SLN metastasis detection rate was 28.5%, whereas eSLNe increased by 3.2%. During follow-up, 4/26 (17.4%) cases in the wSLNe group showed recurrence in the SLN basin. Factors associated with decreased survival in univariant analysis were recurrence, Breslow thickness, advanced clinical stage, ulceration, and SLN metastasis. eSLNe did not affect disease-specific survival. Multivariate analysis showed recurrence (hazard ratio 23.475, 95% confidence interval: 1903-4559, P<0.001) and Breslow thickness of more than 3.5 mm (hazard ratio 15.222, 95% confidence interval: 1448-3059, P<0.001) as independent risk factors for decreased survival. Our routine for SLN examination enabled an adequate rate of SLN metastasis detection and the eSLNe increased the rate of detection in 3.2%, but did not affect the survival. We did not find any benefit from performing the eSLNe in patients with Breslow thickness less than 3.5 mm.
本研究的目的是确定采用不太详尽的病理检查来检测黑色素瘤转移在临床上是否有用,以及是否不会影响患者的预后。前哨淋巴结(SLN)检查的成功与进展取决于组织学技术。已发表了几种详尽的SLN分析方案,但这些方案耗时且成本高,转移检测率仅有轻微提高。对281例行SLN活检的患者,将每个SLN每隔2毫米进行切片,并从每个石蜡块中评估2 - 3个组织学切片。患者分为以下两组:第一组(n = 185)接受广泛的SLN检查(eSLNe),第二组(n = 96)未接受广泛的SLN检查(wSLNe)。切除的SLN平均为2个(范围:1 - 7个),50.9%的患者评估了1个SLN。SLN转移检测率为28.5%,而eSLNe使检测率提高了3.2%。在随访期间,wSLNe组26例中有4例(17.4%)在SLN区域出现复发。单因素分析中与生存率降低相关的因素有复发、Breslow厚度、临床晚期、溃疡和SLN转移。eSLNe不影响疾病特异性生存率。多因素分析显示复发(风险比23.475,95%置信区间:1903 - 4559,P < 0.001)和Breslow厚度超过3.5毫米(风险比15.222,95%置信区间:1448 - 3059,P < 0.001)是生存率降低的独立危险因素。我们的SLN检查流程能够实现足够的SLN转移检测率,eSLNe使检测率提高了3.2%,但不影响生存率。我们未发现对Breslow厚度小于3.5毫米的患者进行eSLNe有任何益处。